Literature DB >> 20139224

Reversible cardiac dysfunction associated with pandemic 2009 influenza A(H1N1).

Seth S Martin1, Caroline L Hollingsworth, Stephanie G Norfolk, Cameron R Wolfe, John W Hollingsworth.   

Abstract

Historical influenza A epidemics have carried elevated rates of cardiovascular disease, including transient cardiac dysfunction. Whether such an association holds for the novel influenza A strain, pandemic 2009 influenza A(H1N1) [A(H1N1)], remains unknown. We report an index case of transient cardiac dysfunction associated with A(H1N1) infection. Next, we reviewed 123 sequential cases of patients hospitalized with pandemic A(H1N1) at a single academic medical center in the United States from April 1, 2009, through October 31, 2009. We identified that 4.9% (6/123) of patients had either new or worsened left ventricular dysfunction. These cases ranged in age from 23 to 51 years, and all had preexisting medical conditions. ICU level care was required in 83% (5/6) of the cases. Sixty-seven percent (4/6) of the cases had follow-up echocardiograms, and left ventricular function improved in all four. We conclude that potentially reversible cardiac dysfunction is a relatively common complication associated with hospitalized pandemic A(H1N1) influenza.

Entities:  

Mesh:

Year:  2010        PMID: 20139224      PMCID: PMC2862401          DOI: 10.1378/chest.10-0032

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  5 in total

Review 1.  Influenza, autoimmunity and atherogenesis.

Authors:  Victor S Gurevich
Journal:  Autoimmun Rev       Date:  2004-11-20       Impact factor: 9.754

2.  Clinical manifestations of influenza a myocarditis during the influenza epidemic of winter 1998-1999.

Authors:  H Onitsuka; T Imamura; N Miyamoto; Y Shibata; T Kashiwagi; T Ayabe; J Kawagoe; J Matsuda; T Ishikawa; T Unoki; M Takenaga; T Fukunaga; S Nakagawa; Y Koiwaya; T Eto
Journal:  J Cardiol       Date:  2001-06       Impact factor: 3.159

Review 3.  Cardiovascular manifestations associated with influenza virus infection.

Authors:  Mamas Andreas Mamas; Doug Fraser; Ludwig Neyses
Journal:  Int J Cardiol       Date:  2008-07-14       Impact factor: 4.164

4.  Influenza A1 myocarditis in conscripts.

Authors:  J Karjalainen; M S Nieminen; J Heikkilä
Journal:  Acta Med Scand       Date:  1980

Review 5.  Influenza as a trigger for acute myocardial infarction or death from cardiovascular disease: a systematic review.

Authors:  Charlotte Warren-Gash; Liam Smeeth; Andrew C Hayward
Journal:  Lancet Infect Dis       Date:  2009-10       Impact factor: 25.071

  5 in total
  20 in total

Review 1.  Impact of H1N1 on socially disadvantaged populations: summary of a systematic review.

Authors:  Andrea C Tricco; Erin Lillie; Charlene Soobiah; Laure Perrier; Sharon E Straus
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

2.  Cardiac complications of influenza infection in 3 adults.

Authors:  Tasha Jeyanathan; Christopher Overgaard; Allison McGeer
Journal:  CMAJ       Date:  2013-04-02       Impact factor: 8.262

3.  Left ventricular myocardial performance in patients with dengue hemorrhagic fever and thrombocytopenia as assessed by two-dimensional speckle tracking echocardiography.

Authors:  Shantanu P Sengupta; Abhijeet Nugurwar; Rahul Jaju; Bijoy K Khandheria
Journal:  Indian Heart J       Date:  2013-04-09

4.  High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination.

Authors:  Jelena Catania; Loretta G Que; Joseph A Govert; John W Hollingsworth; Cameron R Wolfe
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

5.  Atypical clinic presentation of pandemic influenza A successfully rescued by extracorporeal membrane oxygenation - Our experience and review of the literature.

Authors:  Massimo Bonacchi; Marco Ciapetti; Gabriella Di Lascio; Guy Harmelin; Guido Sani; Adriano Peris
Journal:  Interv Med Appl Sci       Date:  2013-12-20

6.  A case series of reversible acute cardiomyopathy associated with H1N1 influenza infection.

Authors:  Mazen Barbandi; Andrea Cordero-Reyes; Carlos M Orrego; Guillermo Torre-Amione; Harrish Seethamraju; Jerry Estep
Journal:  Methodist Debakey Cardiovasc J       Date:  2012-01

Review 7.  Two years after pandemic influenza A/2009/H1N1: what have we learned?

Authors:  Vincent C C Cheng; Kelvin K W To; Herman Tse; Ivan F N Hung; Kwok-Yung Yuen
Journal:  Clin Microbiol Rev       Date:  2012-04       Impact factor: 26.132

8.  Postinfection A77-1726 treatment improves cardiopulmonary function in H1N1 influenza-infected mice.

Authors:  Famke Aeffner; Anna Bratasz; Emilio Flaño; Kimerly A Powell; Ian C Davis
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-07       Impact factor: 6.914

Review 9.  Management of fulminant myocarditis: a diagnosis in search of its etiology but with therapeutic options.

Authors:  Bernhard Maisch; Volker Ruppert; Sabine Pankuweit
Journal:  Curr Heart Fail Rep       Date:  2014-06

10.  Influenza A(H1N1) infection and severe cardiac dysfunction in adults: A case series.

Authors:  Jan A Wiegand; Christian Torgersen; Stefan Bloechlinger; Jukka Takala; Martin W Dünser
Journal:  Wien Klin Wochenschr       Date:  2011-01-19       Impact factor: 1.704

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.